The Effectiveness of E-Cigarettes as Smoking Cessation Tools

Industry Insight by 2FIRSTS.ai
Jan.10.2024
The Effectiveness of E-Cigarettes as Smoking Cessation Tools
E-cigarette is more effective than nicotine gum and other aids in quitting smoking, according to a study by UMass Amherst.

According to a report from the Austrian News Agency on January 10th, a study conducted at the University of Massachusetts Amherst suggests that e-cigarettes are more effective as smoking cessation aids compared to nicotine gum and other auxiliary tools.

 

The study, led by Jamie Hartmann-Boyce, advocates for the recognition of e-cigarettes as a viable cessation tool in the United States.

 

Hartmann-Boyle argues that, unlike in the UK, e-cigarettes should be regarded as an effective tool for smoking cessation in the United States. Smoking has become a major preventable health issue worldwide. He emphasizes that many American smokers wish to quit, and e-cigarettes can serve as an evidence-based option for them.

 

A research team evaluated 88 studies involving over 27,235 participants from the United States, the United Kingdom, and Italy. The results indicate a higher success rate in quitting smoking through the use of e-cigarettes. E-cigarettes work by heating e-liquid, which contains nicotine and flavorings, allowing users to inhale nicotine while avoiding the harmful chemicals produced by traditional cigarettes.

 

According to a study, at least 80% of people who want to quit smoking have successfully done so with the help of e-cigarettes, compared to a success rate of only 60% for those using traditional cessation tools and 40% for those attempting to quit on their own.

 

Hartman-Boys reminds non-smokers to avoid using e-cigarettes, but for smokers, quitting smoking through e-cigarettes can improve their health and reduce risks. He points out that different things may have different effects on different populations, emphasizing the versatility of e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product|LOST MARY Launches "PuffBall," Touted as the First E-Cigarette with Trackball Control, in Russia
Product|LOST MARY Launches "PuffBall," Touted as the First E-Cigarette with Trackball Control, in Russia
The LOST MARY brand recently launched a new e-cigarette, the LOST MARY PuffBall, in Russia. The product is said to feature the industry's first "trackball" design, which allows users to switch modes and control the screen. It is now available on the official Russian website for approximately $14.10.
Sep.12 by 2FIRSTS.ai
2Firsts Connect @ InterTabac Concludes Successfully — Spotlight on Global Landscape, Market Shifts, and Future Opportunities
2Firsts Connect @ InterTabac Concludes Successfully — Spotlight on Global Landscape, Market Shifts, and Future Opportunities
2Firsts Connect @ InterTabac concluded successfully under the theme “From Change to Opportunity,” focusing on the global harm-reduction landscape, shifts in the U.S. market, dynamics in China’s supply chain, vaping product trends, and capital-market opportunities. 2Firsts International Editor-in-Chief Taco Tuinstra, compliance expert Kurt Yang, co-founder Echo Guo, and CEO Alan Zhao shared frontline insights, drawing on UK MHRA registration data and China customs export data to present a compreh
Sep.20
Smoore International Falls Over 6% Again; H1 Net Profit Down Nearly 28%, Short-Term Profitability Pressured by Higher R&D Spending
Smoore International Falls Over 6% Again; H1 Net Profit Down Nearly 28%, Short-Term Profitability Pressured by Higher R&D Spending
Smoore International (06969) continued to decline after its earnings release, falling more than 6% in early trading today. As of press time, the stock was down 5.08% at HK$19.23, with a turnover of HK$466 million.
Aug.28 by 2FIRSTS.ai
Cigar Sense Inc. Announces Research in Cigars to Connect Consumer Expectations, Experiences, and Authentic Brand Storytelling
Cigar Sense Inc. Announces Research in Cigars to Connect Consumer Expectations, Experiences, and Authentic Brand Storytelling
Independent research initiative highlights consumer truth as the new driver of loyalty and meaningful differentiation.
Sep.23
Inter Tabac 2025: 2Firsts Provides Exclusive Coverage of New Tobacco Products and Industry Trends
Inter Tabac 2025: 2Firsts Provides Exclusive Coverage of New Tobacco Products and Industry Trends
2Firsts provides exclusive coverage of Inter Tabac 2025, capturing new tobacco products and industry trends for readers.
Sep.18 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai